Krka (KRKG)

Currency in EUR
221.00
+2.00(+0.91%)
Closed·
Earnings results expected in 12 days
KRKG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
219.00221.00
52 wk Range
148.00225.00
Key Statistics
Bid/Ask
225.00 / 221.00
Prev. Close
219
Open
219
Day's Range
219-221
52 wk Range
148-225
Volume
3.52K
Average Volume (3m)
4.34K
1-Year Change
49.3243%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KRKG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
192.77
Downside
-12.78%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 18 consecutive years

Krka News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Krka Company Profile

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; cerebral and peripheral circulation; vasoprotectives; health care products; and others. In addition, the company offers animal health products comprising antiparasitics, antimicrobials, and other products. Further, the company provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.

Employees
13107
Market
Slovenia

Compare KRKG to Peers and Sector

Metrics to compare
KRKG
Peers
Sector
Relationship
P/E Ratio
16.9x22.5x−0.6x
PEG Ratio
1.46−0.010.00
Price/Book
2.9x1.8x2.6x
Price / LTM Sales
3.4x1.9x3.4x
Upside (Analyst Target)
−8.6%−2.8%41.1%
Fair Value Upside
Unlock16.8%5.3%Unlock

Analyst Ratings

4 Buy
1 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 192.77
(-12.78% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 13.02%
Dividend Yield
3.73%
Industry Median 3.93%
Annualised payout
8.25
Paid annually
5-Years Growth
+14.19%
Growth Streak

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
2.52 / --
Revenue / Forecast
483.25M / --
EPS Revisions
Last 90 days

KRKG Income Statement

FAQ

What Is the Krka (KRKG) Stock Price Today?

The Krka stock price today is 221,00

What Stock Exchange Does Krka Trade On?

Krka is listed and trades on the Ljubljana Stock Exchange stock exchange.

What Is the Stock Symbol for Krka?

The stock symbol for Krka is "KRKG."

Does Krka Pay Dividends? What’s The Current Dividend Yield?

The Krka dividend yield is 3.73%.

What Is the Krka Market Cap?

As of today, Krka market cap is 6.73B.

What Is Krka's Earnings Per Share (TTM)?

The Krka EPS (TTM) is 13.02.

When Is the Next Krka Earnings Date?

Krka will release its next earnings report on 28 Jan 2026.

From a Technical Analysis Perspective, Is KRKG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Krka Stock Split?

Krka has split 1 times.

How Many Employees Does Krka Have?

Krka has 13107 employees.

What is the current trading status of Krka (KRKG)?

As of 17 Jan 2026, Krka (KRKG) is trading at a price of 221,00, with a previous close of 219,00. The stock has fluctuated within a day range of 219,00 to 221,00, while its 52-week range spans from 148,00 to 225,00.

What Is Krka (KRKG) Price Target According to Analysts?

The average 12-month price target for Krka is EUR192.76667, with a high estimate of EUR235 and a low estimate of EUR115. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -12.78% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.